Page 3 - Transcon Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Transcon technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Transcon Technology Today - Breaking & Trending Today

Ascendis Pharma A/S Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™ hGH (Lonapegsomatropin) for Pediatric Growth Hormone Deficiency

COPENHAGEN, Denmark, June 11, 2021 Ascendis Pharma A/S , a biopharmaceutical company that utilizes its innovative TransCon technologies to create new product candidates that address unmet. | June 12, 2021 ....

New Jersey , United States , Palo Alto , Redwood City , Baden Wüberg , Ascendis Pharma , Jan Mikkelsen , Drug Administration , Biologics License Application , Prescription Drug User Fee Act , Chief Executive , Ascendis Pharmaas Stock Exchange , Press Release , Ddress Asnd Us04351p1012 , புதியது ஜெர்சி , ஒன்றுபட்டது மாநிலங்களில் , பாலோ ஆல்டோ , ரெட்வுட் நகரம் , ஜான் மைக்கேல்சன் , உயிரியல் உரிமம் விண்ணப்பம் , ப்ரிஸ்க்ரிப்ஶந் மருந்து பயனர் கட்டணம் நாடகம் , தலைமை நிர்வாகி ,

Ascendis Pharma A/S Announces Participation at Oppenheimer 31st Annual Healthcare Conference

COPENHAGEN, Denmark, March 15, 2021 (GLOBE NEWSWIRE) Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to create product candidates that address unmet medical needs, today announced that the company will participate at the Oppenheimer 31st Annual Healthcare Conference. Company executives will provide a business overview and an update on the Company’s pipeline programs. Details EventOppenheimer 31st Annual Healthcare ConferenceLocationVirtualDateWednesday, March 17, 2021Time11:20 a.m. Eastern Time A live webcast of the presentation will be available on the Investors and News section of the Company’s website at www.ascendispharma.com. A webcast replay will also be available on the Company’s website shortly after conclusion of the event for 30 days. About Ascendis Pharma A/S Ascendis Pharma is applying its innovative TransCon technologies to build a leading, fully integrated biopharmaceutical c ....

Ascendis Pharma , Biopharmaceutical Company , The Company , Development Programs , Product Candidates , Forward Looking Statements , தி நிறுவனம் , வளர்ச்சி ப்ரோக்ர்யாம்ஸ் , ப்ராடக்ட் வேட்பாளர்கள் , முன்னோக்கி பார்க்கிறது அறிக்கைகள் ,

Ascendis Pharma A/S Announces Seven Presentations at ENDO 2021, Demonstrating Commitment to People with Rare Endocrine Diseases

Ascendis Pharma A/S Announces Seven Presentations at ENDO 2021, Demonstrating Commitment to People with Rare Endocrine Diseases
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Ascendis Pharma , Growth Hormone Deficiency , Abstract Number , Biopharmaceutical Company , Poster Presentations , Poster Session , வளர்ச்சி ஹார்மோன் குறைபாடு , போஸ்டர் ப்ரெஸெஂடேஶந்ஸ் , போஸ்டர் அமர்வு ,

Ascendis Pharma A/S Announces New "Outgrow GHD" Educational Resource to Support Rare Disease Day 2021

COPENHAGEN, Denmark, Feb. 26, 2021 (GLOBE NEWSWIRE) Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced the launch of Outgrow GHD, a new online educational resource designed to help caregivers of children with growth hormone deficiency (GHD) in the United States (U.S.) navigate their personal GHD journeys. “We are excited to announce Outgrow GHD to support children with GHD and their families as they manage their lives with this rare endocrine disease. The resource is a place where caregivers of children with this rare disease can learn from and inspire each other,” said Ami Knoefler, Senior Director, Patient Advocacy and Product Communications at Ascendis Pharma. “Outgrow GHD reflects our commitment to improve awareness and understanding of GHD, including its impact on the overall health and well being of a child.” The website offers tools and in ....

Ascendis Pharma , Rare Disease , Biopharmaceutical Company , Growth Hormone Deficiency , ரேர் நோய் , வளர்ச்சி ஹார்மோன் குறைபாடு ,